Karl Beutner

Company: DermBiont

Job title: Chief Executive Officer & Co-Founder

Seminars:

Panel Discussion: Can Topical and Systemic Therapies Each Find Their Place in the Future of Dermatology Drug Development? 4:30 pm

How should we balance the clinical and commercial drivers behind topical and systemic innovation, especially as realworld prescribing habits continue to favor topicals? How are these approaches viewed from the patient, regulator and investor perspective? Which factors, including disease severity, body surface area, and treatment setting, best guide whether a topical, systemic, or combination approach…Read more

day: Day One PM

Rethinking Rare Dermatology: Advancing Topical & Systemic Innovation in Gorlin Syndrome and Dystrophic EB 1:00 pm

Comparing topical and systemic strategies for treating rare dermatologic diseases Highlighting unmet systemic needs and treatment limitations in dystrophic EB Showcasing progress in managing basal cell carcinoma burden in Gorlin syndrome Sharing expanded data and previewing pipeline growth and potential acquisition newsRead more

day: Day Two PM